About this trial
In operating procedure with general anesthesia muscle relaxant is usually used to increase success rate of the operation and to give better outcome. The use of reversal drugs aims to reduce the risk of post-operative complications due to muscle relaxants. Neostigmine is commonly used as a reversal drug, but its indirect mechanism of action results in a long and unpredictable recovery time. Sugammadex directly bind and inactivate rocuronium, in which resulting in a faster and predictable recovery time. However, the high price limits the use of sugammadex.
This study aims to compare the effect of half dose sugammadex and neostigmine against the moderate neuromuscular blockade of rocuronium.
The main questions it aims to answer are:
Does half dose sugammadex gives faster recovery time? Researchers will compare sugammadex to neostigmine to see if sugammadex gives faster recovery time.
Participants will:
Be given sugammadex or neostigmine as a reversal drug after the operation done
Eligibility criteria
Qualifiers
Patients who underwent laparoscopic cholecystectomy under general anesthesia
Using muscle relaxant rocuronium
Aged 18-59 years
American Society of Anesthesiologists (ASA) physical status classification of 1 or 2.
Disqualifiers
History of drug allergies to the agents used
Renal dysfunction
Musculoskeletal disorders
Central nervous system disorders
Trial design
Treatments tested in this trial
- Sugammadex 1 mg/kg
- Neostigmine + Atropine